# Nuclide record sunitinib (drug). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/drugs/sunitinib/>
  a schema:Drug ;
  nuclide:kind "drug" ;
  schema:identifier "sunitinib" ;
  schema:name "Sunitinib"@en ;
  schema:description "Sunitinib is an anti-angiogenic pill approved for pancreatic neuroendocrine tumours, kidney cancer and GIST."@en ;
  schema:url <https://nuclide.cc/drugs/sunitinib/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Sunitinib> ;
  owl:sameAs <http://www.wikidata.org/entity/Q417542> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Sunitinib> ;
  nuclide:status "approved" ;
  nuclide:modality "Small-molecule multi-kinase inhibitor (VEGFR, PDGFR, KIT)" ;
  schema:alternateName "Sutent" ;
  nuclide:approval "US 2006: Advanced RCC; GIST after imatinib", "US 2011: Progressive pancreatic NETs", "US 2017: Adjuvant RCC at high risk (S-TRAC), little used" ;
  nuclide:indications <https://nuclide.cc/indications/neuroendocrine/>, <https://nuclide.cc/indications/rcc/>, <https://nuclide.cc/indications/metastatic-ppgl/> ;
  nuclide:companies <https://nuclide.cc/companies/pfizer/> .